CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Country • United States
    Entity • country not supported, please select another country
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan Better Therapeutics, Inc. - BTTX CFD

    0.6824
    3.61%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.0850
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.024874 %
    Charges from borrowed part ($-0.99)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.024874%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.002651 %
    Charges from borrowed part ($0.11)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.002651%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 0.6586
    Open* 0.6551
    1-Year Change* -66.41%
    Day's Range* 0.6551 - 0.7215
    52 wk Range 0.59-3.23
    Average Volume (10 days) 79.44K
    Average Volume (3 months) 683.76K
    Market Cap 16.62M
    P/E Ratio -100.00K
    Shares Outstanding 23.85M
    Revenue N/A
    EPS -1.69
    Dividend (Yield %) N/A
    Beta -100.00K
    Next Earnings Date May 11, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Mar 31, 2023 0.6824 0.0183 2.76% 0.6641 0.7216 0.6187
    Mar 30, 2023 0.6586 0.0415 6.73% 0.6171 0.7171 0.6144
    Mar 29, 2023 0.6154 -0.0493 -7.42% 0.6647 0.7652 0.5563
    Mar 28, 2023 0.6763 -0.1127 -14.28% 0.7890 0.8036 0.6500
    Mar 27, 2023 0.7928 -0.0307 -3.73% 0.8235 0.8714 0.7751
    Mar 24, 2023 0.8416 0.0196 2.38% 0.8220 0.8910 0.8220
    Mar 23, 2023 0.8616 0.0396 4.82% 0.8220 0.9098 0.8122
    Mar 22, 2023 0.8426 -0.0455 -5.12% 0.8881 0.9106 0.7977
    Mar 21, 2023 0.8779 -0.1091 -11.05% 0.9870 0.9870 0.8709
    Mar 20, 2023 0.9213 -0.0562 -5.75% 0.9775 0.9875 0.8344
    Mar 17, 2023 0.9875 0.0337 3.53% 0.9538 0.9974 0.9277
    Mar 16, 2023 0.9969 -0.0008 -0.08% 0.9977 1.0067 0.9475
    Mar 15, 2023 0.9008 0.0054 0.60% 0.8954 0.9298 0.8857
    Mar 14, 2023 0.9297 0.0047 0.51% 0.9250 1.0170 0.8895
    Mar 13, 2023 1.0070 -0.0383 -3.66% 1.0453 1.0652 1.0070
    Mar 10, 2023 1.0653 0.0004 0.04% 1.0649 1.0749 1.0355
    Mar 9, 2023 1.0946 -0.0286 -2.55% 1.1232 1.1232 1.0647
    Mar 8, 2023 1.0650 0.0107 1.01% 1.0543 1.1330 1.0543
    Mar 7, 2023 1.0844 0.0105 0.98% 1.0739 1.1236 1.0543
    Mar 6, 2023 1.0844 -0.0295 -2.65% 1.1139 1.1233 1.0446

    Better Therapeutics, Inc. Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2021 2020
    Total revenue 0 0
    Total Operating Expense 40.303 0.00169
    Other Operating Expenses, Total 0.00169
    Operating Income -40.303 -0.00169
    Net Income Before Taxes -40.488 -0.00169
    Net Income After Taxes -40.335 -0.00169
    Net Income Before Extra. Items -40.335 -0.00169
    Net Income -40.335 -0.00169
    Income Available to Common Excl. Extra. Items -40.335 -0.00169
    Income Available to Common Incl. Extra. Items -40.335 -0.00169
    Diluted Net Income -40.335 -0.00169
    Diluted Weighted Average Shares 23.6027 7.5575
    Diluted EPS Excluding Extraordinary Items -1.70891 -0.00022
    Dividends per Share - Common Stock Primary Issue 0
    Diluted Normalized EPS -1.4406 -0.00022
    Selling/General/Admin. Expenses, Total 11.124
    Research & Development 19.436
    Unusual Expense (Income) 9.743
    Interest Income (Expense), Net Non-Operating -0.185
    Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
    Total revenue 0 0 0 0 0
    Total Operating Expense 10.996 9.599 9.345 39.7459 0.24039
    Other Operating Expenses, Total -0.55708
    Operating Income -10.996 -9.599 -9.345 -39.7459 -0.24039
    Interest Income (Expense), Net Non-Operating -0.406 -0.329 -0.317 -0.19168 0.00145
    Net Income Before Taxes -11.402 -9.928 -9.662 -39.9376 -0.23894
    Net Income After Taxes -11.405 -9.928 -9.662 -39.7846 -0.23894
    Net Income Before Extra. Items -11.405 -9.928 -9.662 -39.7846 -0.23894
    Net Income -11.405 -9.928 -9.662 -39.7846 -0.23894
    Income Available to Common Excl. Extra. Items -11.405 -9.928 -9.662 -39.7846 -0.23894
    Income Available to Common Incl. Extra. Items -11.405 -9.928 -9.662 -39.7846 -0.23894
    Diluted Net Income -11.405 -9.928 -9.662 -39.7846 -0.23894
    Diluted Weighted Average Shares 23.6931 23.593 23.4132 23.6027 7.5575
    Diluted EPS Excluding Extraordinary Items -0.48136 -0.4208 -0.41267 -1.68559 -0.03162
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.48136 -0.4208 -0.41267 -1.41728 -0.03162
    Selling/General/Admin. Expenses, Total 5.519 5.358 5.672 11.124 0.24039
    Research & Development 5.477 4.241 3.673 19.436
    Unusual Expense (Income) 0 0 0 9.743
    • Annual
    • Quarterly
    2021 2020
    Total Current Assets 45.251 0.08666
    Cash and Short Term Investments 40.566 0.02476
    Cash 0.02476
    Other Current Assets, Total 0.276 0.06189
    Total Assets 50.958 0.08666
    Total Current Liabilities 4.733 0.06334
    Accrued Expenses 3.21 0.00145
    Notes Payable/Short Term Debt 0 0.06189
    Total Liabilities 14.238 0.06334
    Total Long Term Debt 9.505 0
    Total Equity 36.72 0.02331
    Common Stock 0.002 0.00014
    Additional Paid-In Capital 108.461 0.02486
    Retained Earnings (Accumulated Deficit) -71.743 -0.00169
    Total Liabilities & Shareholders’ Equity 50.958 0.08666
    Total Common Shares Outstanding 23.6027 7.5575
    Cash & Equivalents 40.566
    Prepaid Expenses 4.409
    Property/Plant/Equipment, Total - Net 0.082
    Intangibles, Net 5.077
    Other Long Term Assets, Total 0.548
    Accounts Payable 1.523
    Long Term Debt 9.505
    Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
    Total Current Assets 35.179 45.251 0.29171 0.39587 0.52112
    Cash and Short Term Investments 31.673 40.566 0.24846 0.29636 0.3929
    Cash 0.24846 0.29636 0.3929
    Prepaid Expenses 3.242 4.409 0.04325 0.09951 0.12822
    Total Assets 40.291 50.958 57.7984 57.9011 58.0249
    Long Term Investments 57.5067 57.5052 57.5038
    Other Long Term Assets, Total 0.488 0.548 0 0 0
    Total Current Liabilities 3.567 4.733 0.24457 0.10833 0.06833
    Accrued Expenses 2.528 3.21 0.10833 0.06833
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 12.866 14.238 2.25707 2.12083 2.08083
    Total Long Term Debt 9.299 9.505 0 0 0
    Other Liabilities, Total 2.0125 2.0125 2.0125
    Total Equity 27.425 36.72 55.5413 55.7803 55.9441
    Common Stock 0.002 0.002 57.5002 50.7805 50.9443
    Additional Paid-In Capital 108.828 108.461 0 5.3129 5.14908
    Retained Earnings (Accumulated Deficit) -81.405 -71.743 -1.95886 -0.31314 -0.14932
    Total Liabilities & Shareholders’ Equity 40.291 50.958 57.7984 57.9011 58.0249
    Total Common Shares Outstanding 23.6086 23.6027 7.5575 7.5575 7.5575
    Payable/Accrued 0.24457
    Cash & Equivalents 31.673 40.566
    Other Current Assets, Total 0.264 0.276
    Property/Plant/Equipment, Total - Net 0.098 0.082
    Intangibles, Net 4.526 5.077
    Accounts Payable 0.735 1.523
    Long Term Debt 9.299 9.505
    Current Port. of LT Debt/Capital Leases 0.304
    • Annual
    • Quarterly
    2022 2021 2020
    Net income/Starting Line -39.76 -40.335 -0.00169
    Cash From Operating Activities -28.93 -30.818 -0.00024
    Changes in Working Capital 6.268 -2.339 0.00145
    Cash From Financing Activities 5.284 72.332 0.025
    Financing Cash Flow Items 0 62.331 -0.06189
    Issuance (Retirement) of Stock, Net 0.284 0.001 0.025
    Issuance (Retirement) of Debt, Net 5 10 0.06189
    Net Change in Cash -24.826 40.443 0.02476
    Cash From Operating Activities 2.729 1.619
    Deferred Taxes 0 -0.152
    Non-Cash Items 1.833 10.389
    Cash Interest Paid 1.325 0.085
    Cash From Investing Activities -1.18 -1.071
    Capital Expenditures -1.18 -1.071
    Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
    Net income/Starting Line -39.76 -30.995 -19.59 -9.662 -40.335
    Cash From Operating Activities -28.93 -22.593 -15.57 -8.855 -30.818
    Non-Cash Items 1.833 1.384 0.787 0.375 10.389
    Changes in Working Capital 6.268 5.01 1.919 -0.231 -2.339
    Cash From Investing Activities -1.18 -0.82 -0.457 -0.039 -1.071
    Other Investing Cash Flow Items, Total
    Cash From Financing Activities 5.284 5.152 5.146 0.001 72.332
    Financing Cash Flow Items 0 0 0 0 62.331
    Issuance (Retirement) of Stock, Net 0.284 0.152 0.146 0.001 0.001
    Issuance (Retirement) of Debt, Net 5 5 5 10
    Net Change in Cash -24.826 -18.261 -10.881 -8.893 40.443
    Cash From Operating Activities 2.729 2.008 1.314 0.663 1.619
    Deferred Taxes 0 0 0 0 -0.152
    Cash Interest Paid 1.325 0.87 0.462 0.219 0.085
    Capital Expenditures -1.18 -0.82 -0.457 -0.039 -1.071
    Cash Taxes Paid 0
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Perry (David P) Individual Investor 44.5436 10576548 10997 2022-11-01 LOW
    Appelbaum (Kevin J) Individual Investor 10.1623 2412969 0 2022-11-01 LOW
    Mountain Crest Capital LLC Corporation 5.8467 1388250 0 2021-12-31 LOW
    Farallon Capital Management, L.L.C. Hedge Fund 3.4263 813556 -186444 2022-12-31 MED
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.8311 434779 135 2022-12-31 LOW
    Maule-Ffinch (Georgianna) Individual Investor 1.2346 293150 0 2022-11-01 LOW
    Berman Mark A Individual Investor 0.9768 231939 0 2022-11-01 LOW
    Armanino (Andrew J) Individual Investor 0.6935 164662 25000 2022-11-01 LOW
    Carmona (Richard H. M.D.) Individual Investor 0.647 153619 0 2022-11-01 LOW
    Wynholds (Kristin) Individual Investor 0.395 93796 -1242 2022-11-30
    Parker (Geoffrey M) Individual Investor 0.3931 93333 0 2022-11-01 LOW
    Heinen (Mark) Individual Investor 0.3706 88004 18004 2022-11-30 MED
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.3338 79256 532 2022-12-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.2405 57109 -135 2022-12-31 LOW
    Susquehanna International Group, LLP Investment Advisor 0.2274 53989 -17477 2022-12-31 MED
    Karbe (Frank L) Individual Investor 0.2106 50000 0 2022-11-01 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.1904 45200 0 2022-12-31 LOW
    Zamirowski (Justin) Individual Investor 0.1419 36913 36913 2022-05-27
    Leo (Donald R.) Individual Investor 0.0899 21336 0 2022-11-01 LOW
    Group One Trading, L.P. Research Firm 0.0853 20257 20257 2022-12-31 HIGH

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    500K+

    Trader

    92K+

    Klien aktif per bulan

    $53M+

    Volume investasi per bulan

    $30M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Biotechnology & Medical Research (NEC)

    548 Market St. #49404
    SAN FRANCISCO
    CALIFORNIA 94101
    US

    Income Statement

    • Annual
    • Quarterly

    People also watch

    Oil - Crude

    75.76 Price
    +1.830% 1D Chg, %
    Biaya inap posisi Long -0.0156%
    Biaya inap posisi short -0.0063%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.03

    US100

    13,186.80 Price
    +1.680% 1D Chg, %
    Biaya inap posisi Long -0.0249%
    Biaya inap posisi short 0.0027%
    Waktu biaya inap 21:00 (UTC)
    Spread 3.0

    Gold

    1,969.66 Price
    -0.550% 1D Chg, %
    Biaya inap posisi Long -0.0185%
    Biaya inap posisi short 0.0102%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.30

    BTC/USD

    28,401.90 Price
    -0.400% 1D Chg, %
    Biaya inap posisi Long -0.0616%
    Biaya inap posisi short 0.0137%
    Waktu biaya inap 21:00 (UTC)
    Spread 60.00

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda